KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 87 filers reported holding KARUNA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $900,000 | +68.5% | 4,000 | -1.8% | 0.02% | +13.3% |
| Q4 2021 | $534,000 | -90.7% | 4,073 | -91.9% | 0.02% | -93.5% |
| Q2 2021 | $5,718,000 | -2.1% | 50,000 | 0.0% | 0.23% | -12.2% |
| Q1 2021 | $5,839,000 | -24.9% | 50,000 | -33.3% | 0.26% | -65.9% |
| Q4 2020 | $7,772,000 | +207.1% | 75,000 | +114.3% | 0.77% | +235.4% |
| Q4 2019 | $2,531,000 | +1088.3% | 35,000 | +167.6% | 0.23% | +241.8% |
| Q3 2019 | $213,000 | -57.5% | 13,080 | -47.7% | 0.07% | -79.9% |
| Q2 2019 | $501,000 | – | 25,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |